JP2019511525A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019511525A5 JP2019511525A5 JP2018553345A JP2018553345A JP2019511525A5 JP 2019511525 A5 JP2019511525 A5 JP 2019511525A5 JP 2018553345 A JP2018553345 A JP 2018553345A JP 2018553345 A JP2018553345 A JP 2018553345A JP 2019511525 A5 JP2019511525 A5 JP 2019511525A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- composition
- weight ratio
- less
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010038061 Chymotrypsinogen Proteins 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 4
- 206010009944 Colon cancer Diseases 0.000 claims 3
- 206010033128 Ovarian cancer Diseases 0.000 claims 3
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 3
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims 3
- 108010027252 Trypsinogen Proteins 0.000 claims 3
- 102000018690 Trypsinogen Human genes 0.000 claims 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims 3
- 201000002528 pancreatic cancer Diseases 0.000 claims 3
- 208000008443 pancreatic carcinoma Diseases 0.000 claims 3
- 239000004382 Amylase Substances 0.000 claims 2
- 102000013142 Amylases Human genes 0.000 claims 2
- 108010065511 Amylases Proteins 0.000 claims 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 2
- 206010060862 Prostate cancer Diseases 0.000 claims 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 2
- 235000019418 amylase Nutrition 0.000 claims 2
- 208000029742 colonic neoplasm Diseases 0.000 claims 2
- 201000007270 liver cancer Diseases 0.000 claims 2
- 208000014018 liver neoplasm Diseases 0.000 claims 2
- 201000005202 lung cancer Diseases 0.000 claims 2
- 208000020816 lung neoplasm Diseases 0.000 claims 2
- 201000001441 melanoma Diseases 0.000 claims 2
- 208000003174 Brain Neoplasms Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims 1
- 201000008808 Fibrosarcoma Diseases 0.000 claims 1
- 201000003741 Gastrointestinal carcinoma Diseases 0.000 claims 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims 1
- 208000005718 Stomach Neoplasms Diseases 0.000 claims 1
- 208000035250 cutaneous malignant susceptibility to 1 melanoma Diseases 0.000 claims 1
- 201000004101 esophageal cancer Diseases 0.000 claims 1
- 206010017758 gastric cancer Diseases 0.000 claims 1
- 201000002313 intestinal cancer Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662321370P | 2016-04-12 | 2016-04-12 | |
| US62/321,370 | 2016-04-12 | ||
| PCT/AU2017/050323 WO2017177270A1 (en) | 2016-04-12 | 2017-04-12 | Composition of proenzymes for cancer treatment |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019511525A JP2019511525A (ja) | 2019-04-25 |
| JP2019511525A5 true JP2019511525A5 (cg-RX-API-DMAC7.html) | 2020-05-07 |
| JP7004665B2 JP7004665B2 (ja) | 2022-02-04 |
Family
ID=60041280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018553345A Active JP7004665B2 (ja) | 2016-04-12 | 2017-04-12 | 癌治療用の前酵素の組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20190134166A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3442564B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7004665B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN109152823A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017250010A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017177270A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2941348T3 (es) * | 2015-11-12 | 2023-05-22 | Propanc Pty Ltd | Composición de proenzima |
| US12419938B2 (en) | 2015-11-12 | 2025-09-23 | Propanc Pty Ltd | Proenzyme composition |
| ES2965358T3 (es) | 2016-01-29 | 2024-04-15 | Propanc Pty Ltd | Tratamiento del cáncer |
| US11141466B2 (en) * | 2017-06-22 | 2021-10-12 | CSL Behring Lengnau AG | Modulation of FVIII immunogenicity by truncated VWF |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4514388A (en) * | 1983-03-22 | 1985-04-30 | Psaledakis Nicholas G | Proteolytic enzymes in the zymogen form to treat sarcoma cells |
| CZ283972B6 (cs) * | 1995-05-17 | 1998-07-15 | František Mudr. Trnka | Farmaceutický prostředek s modulačním účinkem na zhoubné nádory a jeho použití |
| DK3095458T3 (en) | 2009-10-22 | 2018-11-19 | Propanc Pty Ltd | PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT INCLUDING TRYPSINOGEN AND CHYMOTRYPSINOGEN |
| CZ307195B6 (cs) * | 2013-11-18 | 2018-03-14 | František Trnka | Farmaceutická kompozice obsahující směs proenzymů a enzymů |
| ES2965358T3 (es) | 2016-01-29 | 2024-04-15 | Propanc Pty Ltd | Tratamiento del cáncer |
-
2017
- 2017-04-12 US US16/094,846 patent/US20190134166A1/en not_active Abandoned
- 2017-04-12 WO PCT/AU2017/050323 patent/WO2017177270A1/en not_active Ceased
- 2017-04-12 AU AU2017250010A patent/AU2017250010A1/en not_active Abandoned
- 2017-04-12 JP JP2018553345A patent/JP7004665B2/ja active Active
- 2017-04-12 EP EP17781637.8A patent/EP3442564B1/en active Active
- 2017-04-12 CN CN201780021479.9A patent/CN109152823A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2016161410A3 (en) | Treatment of cancer using inhibitors of tgf-beta and pd-1 | |
| WO2004070062A3 (en) | Compositions and methods for diagnosing and treating cancers | |
| WO2015109180A3 (en) | Compositions and methods for treatment and detection of cancers | |
| JP2019511525A5 (cg-RX-API-DMAC7.html) | ||
| JP2018507249A5 (cg-RX-API-DMAC7.html) | ||
| FI3827838T3 (fi) | Sytokiini-indusoidun sh2-proteiinin estäminen nk-soluissa | |
| CY1117687T1 (el) | Adcs δουοκαρμυκινης που εμφανιζουν βελτιωμενη in vivo αντινεοπλασματικη δραστικοτητα | |
| MX391470B (es) | Inhibidores de idh1 para el tratamiento de neoplasias malignas hematologicas y tumores solidos. | |
| EA201790502A1 (ru) | Ингибиторы гистоновых диметилаз | |
| WO2016123591A3 (en) | Compositions and methods for treatment and detection of cancers | |
| TW201613647A (en) | Compounds and compositions for treating HER2 positive tumors | |
| EA201492004A1 (ru) | Органические композиции для лечения kras-ассоциированных заболеваний | |
| ZA200702973B (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for CDK2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
| CL2012003680A1 (es) | Compuestos derivados de (1,8) naftiridinas 2,4 diaril sustituidas inhibidores de quinasas; su procedimiento de obtencion; composicion farmaceutica; y su uso para el tratamiento y/o prevencion de cancer, tumor, tumores malignos, entre otros; kit farmaceutico. | |
| EA201692483A1 (ru) | Ингибиторы гистоновой метилазы | |
| WO2013093508A3 (en) | Wnt pathway inhibitors | |
| MX2017015210A (es) | Composiciones y metodos para el cribado de tumores solidos. | |
| NZ726365A (en) | Combinations for treating cancers | |
| CR20110479A (es) | Combinaciones farmaceuticas que comprenden rdea 119/bay 869766 para el tratamiento de canceres especificos | |
| CN113366008A (zh) | 一种cd73抑制剂，其制备方法和应用 | |
| EA201101651A1 (ru) | Непрерывное введение интегриновых лигандов для лечения рака | |
| RU2017134148A (ru) | Комбинация тасквинимода или его фармацевтически приемлемой соли и ингибитора pd-1 и/или pd-l1 для применения в качестве лекарственного средства | |
| MX336761B (es) | Compuestos para el tratamiento de cancer. | |
| WO2014165412A3 (en) | Methods and compositions for treating cancers having acquired resistance to chemotherapeutic and targeted drugs using carboxyamidotriazole orotate | |
| WO2020115491A3 (en) | Immune checkpoint inhibitor in combination with sonodynamic therapy |